rss
J Am Med Inform Assoc 2002;9:230-238 doi:10.1197/jamia.M0997
  • The Practice of Informatics
  • Review Paper

Design and Analysis of Controlled Trials in Naturally Clustered Environments

Implications for Medical Informatics

  1. Jen-Hsiang Chuang,
  2. George Hripcsak,
  3. Daniel F Heitjan
  1. Affiliations of the authors: Columbia University, New York, New York (J-HC, GH, DF); National Yang-Ming University, Taipei, Taiwan (JHC)
  1. Correspondence and reprints: Jen-Hsiang Chuang, MD, MS, Department of Medical Informatics, Columbia University, 622 West 168th Street, Vanderbilt Clinic, 5th Floor, New York, NY 10032; e-mail: <chuangj{at}dmi.columbia.edu>
  • Received 1 August 2001
  • Accepted 3 January 2002

Abstract

In medical informatics research, study questions frequently involve individuals who are grouped into clusters. For example, an intervention may be aimed at a clinician (who treats a cluster of patients) with the intention of improving the health of individual patients. Correlation among individuals within a cluster can lead to incorrect estimates of the sample size required to detect an effect and inappropriate estimates of the confidence intervals and the statistical significance of the intervention effects. Contamination, which is the spread of the effect of an intervention or control treatment to the opposite group, often occurs between individuals within clusters. It leads to an attenuation of the effect of the intervention and reduced power to detect a difference. If individuals are randomized in a clinical trial (individual-randomized trial), then correlation must be taken into account in the analysis, and the sample size may need to be increased to compensate for contamination. Randomizing clusters rather than individuals (cluster-randomized trials) can eliminate contamination and may be preferred for logistical reasons. Cluster-randomized trials are generally less efficient than individual-randomized trials, so the tradeoffs must be assessed. Correlation must be taken into account in the analysis and in the sample-size calculations for cluster-randomized trials.

Footnotes

  • This work was supported in part by grant R01 LM06910 from the National Library of Medicine and grant R01 HL65365 from the National Institutes of Health. Dr. Chuang was supported in part by the Medical Foundations in Memory of Dr. Chi-Shuen Tsou and Dr. Albery Ly-Young Shen, Taiwan.

Access policy for JAMIA

All content published in JAMIA is deposited with PubMed Central by the publisher with a 12 month embargo. Authors/funders may pay an Unlocked fee of $2,000 to make the article free on the JAMIA website and PMC immediately on publication.

All content older than 12 months is freely available on this website.

AMIA members can log in with their JAMIA user name (email address) and password or via the AMIA website.